JTT-130, a Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Improves Hyperglycemia and Dyslipidemia Independent of Suppression of Food Intake in Diabetic Rats

Figure 5

Hepatic triglyceride (a) and total cholesterol (b) levels in control group, JTT-130 treatment group, and pair-fed group. Necropsy was performed on day 41 of treatment and the lipid levels were measured. Data represent mean values + s.d. (𝑛=5-6). ^∗𝑃<0.05: significantly different from control group. ^##𝑃<0.01: significantly different from pair-fed group.

(a)

(b)